Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, October 31 2014 5:40pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
Latest News
Friday, Oct 31, 2014
·Bristol-Myers Squibb Up on Positive Opdivo Phase II Study
Zacks.com - 1 hour, 5 minutes ago
·Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata
PR Newswire - 1 hour, 25 minutes ago
·Will Zoetis (ZTS) Pull a Surprise this Earnings Season?
Zacks.com - 1 hour, 30 minutes ago
·Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected?
Zacks.com - 2 hours, 20 minutes ago
·Mylan (MYL) Earnings Report: Q3 2014 Conference Call Transcript
at TheStreet.com - Fri 11:16 am ET
·Perilous Reversal Stock: AVANIR Pharmaceuticals (AVNR)
at TheStreet.com - Fri 10:19 am ET
·Mylan (MYL) Highlighted As Momo Momentum Stock
at TheStreet.com - Fri 9:50 am ET
·Strong And Under The Radar: Zoetis (ZTS)
at TheStreet.com - Fri 9:46 am ET
·Mylan Beats, Raises Earnings Guidance; Abbott Deal on Track
Zacks.com - Fri 8:00 am ET
·NephroGenex to Participate in Two Healthcare Conferences in November
Business Wire - Fri 8:00 am ET
·Horizon Pharma plc Announces DUEXIS(R) Selected as Winner of Chicago Innovation Award
Marketwire - Fri 8:00 am ET
Thursday, Oct 30, 2014
·[$$] Mylan Profit Soars As Revenue Tops Estimates
at The Wall Street Journal Online - Thu 5:16 pm ET
·Mylan (MYL) Stock Higher In After-Hours Trading Following Third Quarter Earnings Results
at TheStreet.com - Thu 5:09 pm ET
·Pfizer's Trumenba Gains Accelerated Approval in the U.S.
Zacks.com - Thu 5:04 pm ET
·Mylan beats Street 3Q forecasts
AP - Thu 4:31 pm ET
·Dr. Reddy's (RDY) Q2 Earnings Fall, Revenues Up Y/Y
Zacks.com - Thu 4:20 pm ET
·Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16
PR Newswire - Thu 4:05 pm ET
·Fibrocell Science to Report Third Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on November 7, 2014
GlobeNewswire - Thu 4:05 pm ET
·The Medicines Company to Webcast Investor & Analyst Day on November 5
Business Wire - Thu 4:01 pm ET
·Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "Headache"
PR Newswire - Thu 4:01 pm ET
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
www.OmegaStatistics.com
74 Year Old's Skin Secret
The Ultimate Skin Tightening Remedy Helping Older Women Look Younger
www.lifecellcream.com
M/A/R/C Research
Custom Research
www.MARCresearch.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?